AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection

RecruitingPhase 3Ages 19 Years - anyAllTanta University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

this Study Evaluating Safety and Effectiveness of (Proton Pump Inhibitor versus Vonoprazan) Based Triple Therapy with or without Zinc to Eradicate H. pylori Infection

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age \> 18. * Both males and females. * Patients who are positive for H.pylori infection by non-invasive Stool Antigen Test (SAT). Exclusion Criteria: * Prior H. pylori treatment: Previous treatment for H. pylori infection. * Allergies: Known allergies to study medications or components. * Patients cannot finish treatment course. * Pregnant and Lactating Women. * Patients with Kidney disease and eGFR \< 30ml/min. * Patients with Liver disease with Child-Pugh B or C.
๐Ÿ’Š

What it tests

  • zinc sulfate
  • Vonoprazan + amoxicillin + clarithromycin
  • proton pump inhibitor + amoxicillin
๐Ÿ“

Where

1 site
National Liver Institute
Shibฤซn al Kawm, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy